Rockefeller Capital Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,018
| Closed | -$8K | – | 3311 |
|
|
2022
Q4 | $8K | Buy |
1,018
+527
| +107% | +$4.14K | ﹤0.01% | 3188 |
|
|
2022
Q3 | $2K | Sell |
491
-826
| -63% | -$3.37K | ﹤0.01% | 3614 |
|
|
2022
Q2 | $4K | Sell |
1,317
-75,579
| -98% | -$230K | ﹤0.01% | 3561 |
|
|
2022
Q1 | $699K | Buy |
76,896
+76,582
| +24,389% | +$696K | ﹤0.01% | 1191 |
|
|
2021
Q4 | $5K | Buy |
+314
| New | +$5K | ﹤0.01% | 3282 |
|
|
2021
Q3 | – | Sell |
-4,413
| Closed | -$153K | – | 3808 |
|
|
2021
Q2 | $153K | Sell |
4,413
-461
| -9% | -$16K | ﹤0.01% | 1625 |
|
|
2021
Q1 | $161K | Sell |
4,874
-1,456
| -23% | -$48.1K | ﹤0.01% | 1395 |
|
|
2020
Q4 | $164K | Buy |
+6,330
| New | +$164K | ﹤0.01% | 1259 |
|